Trial With Metformin in Women With Polycystic Ovary Syndrome

• Status: Completed
• Trial end date: 2002-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

The investigators wanted to elucidate the effects of metformin in Polycystic Ovary Syndrome (PCOS) by performing a randomized, double-blinded, placebo-controlled cross-over study.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Herning Hospital
• Collaborator: GEA A/S Denmark
• Treatments: Metformin

Criteria

Inclusion Criteria:

• testosterone value above the upper normal limit and

• oligo- or amenorrhea,

Exclusion Criteria:

• periclimacteric gonadotrophin values,

• hyperprolactinaemia,

• diabetes mellitus,

• impaired thyroid,

• renal or hepatic function,

• hormonal treatment,

• pregnancy,

• lactation or a wish for fertility treatment.